Extend your learning Learn about effective ways to address problematic opioid use and overdose. DPA has an action plan that outlines a robust response focused on effective treatment, harm reduction, prevention, and… Read More
Browse Our Resources
The U.S. Food and Drug Administration (FDA) has approved three medications for use in treating opioid dependence: methadone, buprenorphine, and naltrexone. Extended release naltrexone, brand name Vivitrol®, is a… Read More
Under HAT, pharmacological heroin is administered under strict controls in a clinical setting to those who have failed in other treatments like methadone. Every published evaluation of HAT has shown extremely positive… Read More
This fact sheet explains how 911 Good Samaritan laws can save lives. These laws protect people from arrest and prosecution for drug possession when they call 911 to report an overdose.
List of states with 911 Good Samaritan laws and/or naloxone access policies in place.
Watch the recording now! Harm reduction services and syringe exchange are more than just a prevention strategy. Access to these vital services enables HIV testing, linkage to care and other critical health/social… Read More
Statement of Support
On April 7, 2015, Ethan Nadelmann, Executive Director of the Drug Policy Alliance, presented oral testimony in support of sections 11-20 of SB275 at a hearing of the Nevada State Senate Revenue and Economic Development… Read More
This report reflects a new evolution in the thinking of the Global Commission, which includes Kofi Annan, Richard Branson, and the former presidents of Brazil, Chile, Colombia, Mexico, Poland, Portugal and Switzerland.… Read More
There is an extensive body of literature documenting the stigma associated with alcohol and other drug problems. No physical or psychiatric condition is more associated with social disapproval and discrimination than… Read More